Correction: Suriya et al. Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site. <i>Pharmaceutics</i> 2022, <i>14</i>, 1461
In the original publication [...]
Saved in:
| Main Authors: | Utid Suriya, Panupong Mahalapbutr, Thanyada Rungrotmongkol |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/4/419 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors: in vitro and in silico studies
by: Sahachai Sabuakham, et al.
Published: (2024-12-01) -
Discovery of bis-thiourea derivatives as potent tyrosinase inhibitors: combined experimental and computational study
by: Sahachai Sabuakham, et al.
Published: (2025-12-01) -
Expression Analysis of the Extensive Regulation of Mitogen-Activated Protein Kinase (MAPK) Family Genes in Buckwheat (<i>Fagopyrum tataricum</i>) During Organ Differentiation and Stress Response
by: Guoqing Dong, et al.
Published: (2024-11-01) -
In-silico analysis of potential phytochemicals targeting mitogen activating protein kinase-14 (MAPK14) gene in colorectal cancer
by: Meerab Khalid, et al.
Published: (2025-07-01) -
In Silico Study of FDA-Approved Drugs on <i>Leishmania infantum</i> CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis
by: Juan Diego Guarimata, et al.
Published: (2024-11-01)